Data / Form D filings / Dynamis Pharmaceuticals, Inc.
Dynamis Pharmaceuticals, Inc.: Form D filings
Dynamis Pharmaceuticals, Inc., a pharmaceuticals company in Jenkintown, PA, filed 4 Form D notices with the SEC between 2017 and 2018. The latest, on August 30, 2018, reports $457,993 sold of a $457,993 offering to 16 investors.
Find out what Dynamis Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 261 OLD YORK ROAD, SUITE 427, Jenkintown, PA, 19046
- Phone
- (215) 376-5290
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1708606
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 30, 2018 | New notice | $457,993 | $457,993 | $0 | 16 | Aug 16, 2018 | sec.gov |
| Jun 13, 2018 | Amendment | Indefinite | $539,000 | Indefinite | 15 | Jun 14, 2017 | sec.gov |
| Apr 25, 2018 | Amendment | Indefinite | $489,000 | Indefinite | 15 | Jun 14, 2017 | sec.gov |
| Jun 21, 2017 | New notice | Indefinite | $404,000 | Indefinite | 13 | Jun 14, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Smith | Executive Officer, Director | |
| Annette Tobia | Executive Officer, Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Aug 27, 2018 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Dynamis Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.